Envoy Medical, Inc. (COCHW)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 100K 200K 300K Q3 '24: 278K Q4 '24: 225K Q1 '25: 212K Q2 '25: 222K Q3 '25: 208K Q4 '25: 241K Q1 '26: 234K Q2 '26: 207K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

-900K -600K -300K 0 300K 600K 900K Q3 '24: -541K Q4 '24: -517K Q1 '25: -603K Q2 '25: -582K Q3 '25: -612K Q4 '25: -633K Q1 '26: -727K Q2 '26: -798K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-27M -18M -9M 0 9M 18M 27M Q3 '24: -21.4M Q4 '24: -19.3M Q1 '25: -19.5M Q2 '25: -19.7M Q3 '25: -20.4M Q4 '25: -22.3M Q1 '26: -23.1M Q2 '26: -23.6M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-27M -18M -9M 0 9M 18M 27M Q3 '24: -21.1M Q4 '24: -20.8M Q1 '25: -19.5M Q2 '25: -21.3M Q3 '25: -21.8M Q4 '25: -23.8M Q1 '26: -23.1M Q2 '26: -23.4M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 350K 700K 1.1M Q3 '24: 819K Q4 '24: 742K Q1 '25: 815K Q2 '25: 804K Q3 '25: 820K Q4 '25: 874K Q1 '26: 961K Q2 '26: 1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

-27M -18M -9M 0 9M 18M 27M Q3 '24: -24M Q4 '24: -17.9M Q1 '25: -16.1M Q2 '25: -15.9M Q3 '25: -17.6M Q4 '25: -18.2M Q1 '26: -20.5M Q2 '26: -21.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

-21M -14M -7M 0 7M 14M 21M Q3 '23: -8.5M Q4 '23: -17.2M Q1 '24: -19.9M Q4 '25: -18.4M Q3 '23 Q4 '23 Q1 '24 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q1 '24: 18.6M Q2 '24: 18.6M Q3 '24: 18.6M Q1 '25: 21.3M Q2 '25: 21.4M Q3 '25: 21.9M Q1 '26: 68.9M Q2 '26: 104M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.80 -1.20 -0.60 0.00 0.60 1.20 1.80 Q3 '24: -1.17 Q4 '24: -1.49 Q1 '25: -1.37 Q2 '25: -1.40 Q3 '25: -1.36 Q4 '25: -1.22 Q1 '26: -1.01 Q2 '26: -0.76 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.